LINC00520 and head and neck squamous cell carcinoma: LINC00520 can bind miR-195, thereby up-regulating HOXA10, inhibiting the radiosensitivity of HNSCC, and promoting the proliferation, migration, invasion, and survival of HNSCC cells (19).